Evolent announces appointment of Archie Mayani as chief product officer
- Industry veteran brings track record of innovation from GHX, Change Healthcare, UnitedHealth Group and Amazon.
WASHINGTON, March 19, 2026 /PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH), a company focused on achieving better health outcomes for people with complex conditions, today announced the appointment of health care technology leader and AI innovator Archie Mayani as chief product officer (CPO).
Mayani brings more than two decades of leadership experience across health care, enterprise platforms, and AI, with a history of building products that improve clinical and business outcomes at scale.
Before joining Evolent, she served as CPO at GHX, where she helped pioneer AI-powered capabilities to strengthen the resilience of the global health care supply chain. Prior to GHX, Mayani was CPO at Change Healthcare, where she led products across clinical decision support, enterprise imaging and revenue cycle platforms, driving innovations that helped reduce administrative burden in prior authorization for both providers and payers. Earlier in her career, in leadership roles at Optum and UnitedHealth Group, she helped scale value-based care through population health and preventive care programs that improved customer satisfaction, raised Medicare STARS performance, and reduced avoidable hospital and emergency department utilization.
Earlier, Mayani also served as global head of product and content operations for Amazon Prime Video during significant catalog growth, while transforming the operations with machine-learning based optimization.
"We are thrilled to have Archie on board to accelerate Evolent's product strategy," said Evolent President Dan McCarthy. "Her deep knowledge of value-based care, health tech and prior authorization, combined with her impressive track record of delivering innovation and AI transformation at scale, made her an ideal hire to drive best-in-class performance for our products and platforms. Our ability to attract visionary leaders such as Archie is a testament to our market leadership, our culture, and our vision to improve the quality and affordability of specialty care."
Mayani has received several industry honors, including the Inspiring Leader Award at the Health 2.0 conference in 2023, Top 50 Women Leaders of San Francisco in 2023, and Global CPO Award Winner by Products that Count in 2025. She is a frequent speaker on responsible AI, product innovation and the future of health care.
"This is a crucial opportunity at a time when AI is fundamentally reshaping health care," said Mayani. "Evolent has the foundation, the mission, and the trust to lead. I am excited to help bring our products, our enormous proprietary datasets, and AI together to create smarter experiences and greater value across the health care ecosystem."
Evolent (NYSE: EVH) specializes in better health outcomes for people with complex conditions through proven solutions that make health care simpler and more affordable. Evolent serves a national base of leading payers and providers and is consistently recognized as a top place to work in health care nationally. Learn more about how Evolent is changing the way health care is delivered by visiting evolent.com.
SOURCE Evolent Health, Inc.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
VALERO ENERGY CORP <VLO.N>: JEFFERIES CUTS TARGET PRICE TO $394 FROM $401
VALERO ENERGY CORP : JEFFERIES CUTS TARGET PRICE TO $394 FROM $401
Gold prices rise Rs 1,500/10g; silver up Rs 3,100/kg ahead of US economic data, softer yields. Buy, sell or hold?
The Shopify Stock Rally Isn't Done: Chart of the Week -- Barrons.com
By Doug Busch Shopify is no longer a pandemic-era growth story that simply failed to slow down. It is compounding at a pace few software platforms its size still manage. In the second quarter of 2026, sales on its platform rose 32%. That was the fifth straight quarter of growth exceeding 30%. Merchants are also using more of Shopify's own tools, from payments to Shop Pay, and new channels like AI shopping agents are starting to increase demand. The simple bull case is that the stock already commands a huge share of independent online commerce, and that position should become more valuable as more buying moves through its checkout. A rule of market mechanics is that the vast majority of an individual security's gain is driven by its underlying sector. Within technology, software has staged a robust recovery, joining semiconductors to power the broader sector higher. The iShares Expanded Tech-Software Sector ETF has maintained an upward trajectory since its mid-April lows, though the advance from $74 to $112 has been choppy as bulls repeatedly stepped in to defend when necessary. Breadth across large-cap software has expanded significantly, with 24 constituents surging over 20% over the past three months. During that same three-month window, Shopify generated outstanding relative strength, advancing 36%, more than doubling the IGV's 17% gain over the same period. Expect the stock's outperformance to persist as software momentum broadens. Let's examine the daily and monthly charts to outline the technical drivers behind this thesis. Looking at the daily chart, the ratio chart against the IGV shows persistent outperformance extending back to mid-May. The stock is riding an eight-session winning streak, during which price action cleared a double-bottom-with-handle pivot at $151.39. Within this broader base, the stock recorded a bullish golden cross in late August and successfully filled its Sept. 10 price gap, tracing back to its Aug. 4 session, the day before a powerful earnings reaction sent the stock surging 17% hi
Crypto prices
More
